Technology
Health
Biotechnology

Sinovac Biotech

$6.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can watch SVA and buy or sell other stocks, options, ETFs, and crypto commission-free!

About

Sinovac Biotech, Ltd. Ordinary Shares, also called Sinovac Biotech, is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Read More Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Employees
644
Headquarters
Beijing, Beijing
Founded
1993
Market Cap
370.61M
Price-Earnings Ratio
12.90
Dividend Yield
0.00
Average Volume
26.39K
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$8.66
52 Week Low
$5.73

Collections

Technology
Health
Biotechnology
China
Asia

News

Associated PressMar 11

Sinovac’s Poison Pill Attempt Stopped by Court Orders

BOSTON and BEIJING, March 11, 2019 (GLOBE NEWSWIRE) -- In a court order dated March 6, 2019, the Honorable J. Travis Laster of the Delaware Court of Chancery ordered Sinovac Biotech Ltd.

40
Associated PressMar 8

Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares

BEIJING--(BUSINESS WIRE)--Mar 8, 2019--Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common and Series B Preferred Shares announced February 22, 2019. On February 22, 2019, as announced by press release, the Sinovac Board of Directors effectuated an Exchange of Rights held by certain Sinovac’s shareholders for a combination of approximately 27.8 million Common Shares and approxi...

15
Seeking AlphaFeb 22

Sinovac Bio shares halted

Nasdaq has suspended trading in Sinovac Biotech (SVA -0.3% ) pending the receipt of certain information requested by Nasdaq....

1

Earnings

$0.00
$0.04
$0.07
$0.11
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.